Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia.
Castillo JJ, Branagan AR, Sermer D, Flynn CA, Meid K, Little M, Stockman K, White T, Canning A, Guerrera ML, Kofides A, Liu S, Liu X, Richardson K, Tsakmaklis N, Patterson CJ, Hunter ZR, Treon SP, Sarosiek S.
Castillo JJ, et al. Among authors: liu x, liu s.
Blood. 2024 Feb 15;143(7):582-591. doi: 10.1182/blood.2023022420.
Blood. 2024.
PMID: 37971194
Free PMC article.